About Covance by Labcorp

Contact Us

Covance by Labcorp is a leading contract research organization (CRO) that provides contract research services to the药品,医疗设备和诊断,作物保护和化学工业.

我们在全球范围内雇用超过26,000人,我们提供全面的药物开发解决方案,并采用了促进健康和能力明确,自信的决策的使命。

Labcorp的Covance是非临界安全评估,临床试验和临床试验管理服务的全球领导者。我们独特的观点是基于几十年的科学,医疗和监管专业知识。

Together with our clients, we support the development of innovative, life-changing treatments.

About Labcorp

Labcorpis a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.

通过我们无与伦比的诊断和研究开发能力,我们提供见解和加速创新,以改善健康,改善生命。

With more than 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14.0 billion in FY2020. Learn about Labcorp atwww.Labcorp.com, or follow us onlinkedin.and Twitter@Labcorp.

Our Mission

To improve health and improve lives.

我们的愿景

要被客户识别为:

  • The undisputed leader in providing drug development services
  • Atrusted partner谁的标志是
    • Great people
    • High-quality data
    • A proven track record of integrating and streamlining the development process

Our Values

To strive for operational and service excellence through a relentless focus on People, Process and Clients.

我们的历史

YEAR MILESTONE
2015 LabCorp®(纽约证券交易所:LH)收购了Covance Inc.,创建了世界领先的医疗保健诊断公司,为药物和诊断开发和商业化提供全面的临床实验室服务和最终对端解决方案。
2011 Takeda Pharmaceuticals International,Inc。选择Covance作为其战略合作伙伴之一,以计划和执行全球发展计划,以支持除肿瘤的所有治疗区域中的新化合物。
2010 Covance与Sanofi-Aventis签署了地标协议,为10年战略性的研发联盟,并收购了他们的Porcheville,法国和阿尼克,英国网站。
2009

Covance acquires Merck's Seattle-based Gene Expression Laboratory. Under the agreement, Merck has committed to a five-year $145 million contract to purchase genomic analysis services from Covance.

Covance acquires Swiss Pharma Contract, a clinical research company based in Basel, Switzerland.

2008

Covance purchases minority equity stake in Caprion Proteomics, the leading provider of proteomics-based services to the pharmaceutical industry, to further enhance its biomarkers service offering to clients.

Covance makes CRO history with the most comprehensive drug development partnership in the industry. Covance acquires Lilly’s Greenfield, Indiana campus and executes a 10-year service agreement with Lilly.

2007

In celebration of their 10-year anniversary, Covance announces our partnership with CARE to support the Covance-CARE Early Childhood Development (ECD) Initiative for Orphans and Vulnerable Children in Rwanda.

Covance opens Central Labs facility in Shanghai, China.

2006 Covance宣布收购Radiant Research的八个早期临床药理学遗址,Inc。在威斯康星州麦迪逊开启最大的毒理学扩张。
2002 Covance收购虚拟中央实验室,现在称为本地实验室服务。
2000

中央斯特氏实验室在新加坡开放,以服务于快速增长的东亚市场。

Covance在Leeds,U.K中扩大了Harrogate,U.K.和I阶段临床研究单位的药物分析设施。

1998年 Covance获得伯克利(加利福尼亚)抗体公司。
1997年 在我们的官方分拆到康宁队的官方拆卸后,届康司队以纽约证券交易所(纽约证券交易所)为独立的公开交易公司。

Let's start a conversation

Contact Us